S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners

SPDR MSCI ACWI ex-US ETF (CWI) Price, Holdings, & News

$26.09
+0.07 (+0.27%)
(As of 11/28/2023 ET)
Compare
Today's Range
$25.97
$26.15
50-Day Range
$23.83
$26.11
52-Week Range
$23.78
$27.12
Volume
257,093 shs
Average Volume
436,734 shs
Market Capitalization
$1.58 billion
Assets Under Management
$1.49 billion
Dividend Yield
2.91%
Net Expense Ratio
0.30%
CWI stock logo

About SPDR MSCI ACWI ex-US ETF (NYSEARCA:CWI)

SPDR MSCI ACWI ex-US ETF (the Fund) seeks to closely match the returns and characteristics of the total return performance of the MSCI ACWI ex USA Index (the Index). The Index is a float-adjusted market capitalization index that is designed to measure the combined equity market performance of developed and emerging market countries excluding the United States. The Fund’s investment advisor is SSgA Funds Management, Inc.

CWI Stock Price History

CWI ETF News Headlines

IMIE ETF Stock Price History
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
SPDR® MSCI World Energy UCITS ETF (ENGW)
New Buy Rating for MSCI (MSCI), the Technology Giant
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
See More Headlines
Receive CWI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SPDR MSCI ACWI ex-US ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
SSgA
Fund Name
SPDR MSCI ACWI ex-US ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:CWI
Inception Date
1/10/2007
Fund Manager
Michael Feehily, Karl Schneider, Michael Finocchi
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
MSCI ACWI ex-US Index
Category
Broad Equity
Focus
Size and Style
Development Level
Blended Development
Region
Global ex-U.S.
Number of Holdings
1382

Fund Statistics

Assets Under Management
$1.49 billion
Average Daily Volume
$479,199.40
Discount/Premium
0.06%

Administrator, Advisor and Custodian

Administrator
SSgA Funds Management, Inc.
Advisor
SSgA Funds Management, Inc.
Custodian
State Street Bank and Trust Company
Distributor
State Street Global Advisors Funds Distributors, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Susquehanna

Options

Optionable
N/A
Short Interest
467,600 shs

Miscellaneous

Beta
0.82
Creation Unit
200,000
Creation Fee
$12,000.00
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

SPDR MSCI ACWI ex-US ETF Expenses

TypeCWISize and Style ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.30%0.45%0.53%0.50%0.51%
Other Expenses0.00%0.69%0.53%0.64%0.57%
Total Expense0.30%0.61%0.69%0.73%0.69%
Fee Waiver0.00%-0.72%-0.54%-0.69%-0.57%
Net Expense0.30%0.47%0.59%0.57%0.57%

SPDR MSCI ACWI ex-US ETF (CWI) Holdings & Exposure

Top 10 CWI Holdings

  • Taiwan Semiconductor Manufacturing(NYSE:TSM)
    Holding Weight: 1.71%
  • NESTLE SA REG
    Holding Weight: 1.43%
  • ASML HOLDING NV
    Holding Weight: 1.17%
  • NOVO NORDISK A/S B
    Holding Weight: 1.12%
  • SAMSUNG ELECTR GDR REG S
    Holding Weight: 1.12%
  • TENCENT HOLDINGS LTD
    Holding Weight: 1.10%
  • LVMH MOET HENNESSY LOUIS VUI
    Holding Weight: 1.09%
  • ROCHE HOLDING AG GENUSSCHEIN
    Holding Weight: 0.95%
  • NOVARTIS AG REG
    Holding Weight: 0.91%
  • SHELL PLC
    Holding Weight: 0.87%

CWI Sector Exposure

CWI Industry Exposure

Key Executives

  • Frank Nesvet (Age 69)
    Independent Chairman of the Board of Trustees
  • James E. Ross (Age 52)
    President, Trustee
  • Julie B. Piatelli (Age 45)
    Chief Compliance Officer
  • Ellen M. Needham (Age 46)
    Vice President
  • Michael P. Riley (Age 44)
    Vice President
  • Gary L. French (Age 64)
    Treasurer
  • Matthew W. Flaherty (Age 42)
    Assistant Treasurer
  • Chad C. Hallett (Age 47)
    Assistant Treasurer
  • Laura Healy (Age 52)
    Assistant Treasurer
  • Ryan M. Louvar (Age 42)
    Assistant Secretary














CWI ETF - Frequently Asked Questions

How have CWI shares performed in 2023?

SPDR MSCI ACWI ex-US ETF's stock was trading at $24.06 on January 1st, 2023. Since then, CWI shares have increased by 8.4% and is now trading at $26.09.
View the best growth stocks for 2023 here
.

What does CWI invest in?

SPDR MSCI ACWI ex-US ETF is a equity fund issued by SSgA. CWI focuses on size and style investments and follows the MSCI ACWI ex-US Index. The fund's investments total to approximately $1.49 billion assets under management.

What is the management fee for SPDR MSCI ACWI ex-US ETF?

SPDR MSCI ACWI ex-US ETF's management fee is 0.30% and has no other recorded expenses or fee waivers. The net expense ratio for CWI is 0.30%.

Who are SPDR MSCI ACWI ex-US ETF's major shareholders?

SPDR MSCI ACWI ex-US ETF's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include PNC Financial Services Group Inc. (5.25%), Synovus Financial Corp (2.95%), Avantax Planning Partners Inc. (2.60%), Hengehold Capital Management LLC (2.55%), HighTower Advisors LLC (2.41%) and LPL Financial LLC (2.32%).

How do I buy shares of SPDR MSCI ACWI ex-US ETF?

Shares of CWI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSEARCA:CWI) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -